Clovis Oncology, Inc.
CLVS
CLVS was delisted on the 20th of December, 2022.
137 hedge funds and large institutions have $1.87B invested in Clovis Oncology, Inc. in 2014 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 64 increasing their positions, 25 reducing their positions, and 10 closing their positions.
260% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 10
156% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 25
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
36% more call options, than puts
Call options by funds: $31.7M | Put options by funds: $23.3M
23% more capital invested
Capital invested by funds: $1.52B → $1.87B (+$356M)
22% more funds holding
Funds holding: 112 → 137 (+25)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OppenheimerFunds
New York
|
+$62.5M |
| 2 |
VAM
Visium Asset Management
New York
|
+$43.9M |
| 3 |
HM
HealthCor Management
New York
|
+$27.6M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$25.5M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$22.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$111M |
| 2 |
SCA
SAC Capital Advisors
Stamford,
Connecticut
|
-$52M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$18.1M |
| 4 |
PIM
Partner Investment Management
San Francisco,
California
|
-$8.67M |
| 5 |
WSA
Wall Street Associates
Lajolla,
California
|
-$6.32M |
CLVS Hedge Fund Activity: Q1 2014 in Review
137 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Clovis Oncology, Inc. (CLVS) for Q1 2014, worth a combined $1.87B — up 23% from $1.52B a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new CLVS positions and 10 closed out — a net gain of 26 holders — while 64 added to existing stakes and 25 trimmed.
The largest buyer was OppenheimerFunds, opening a new position worth an estimated $62.5M. The largest seller was PFM Health Sciences, cutting an estimated $111M.
- 137 institutional investors held Clovis Oncology, Inc. (CLVS) as of Q1 2014, up from 112 in Q4 2013.
- Funds reported $1.87B of Clovis Oncology, Inc. stock for Q1 2014, up 23% quarter-over-quarter.
- 36 funds opened new Clovis Oncology, Inc. positions in Q1 2014 and 10 closed out, a net change of +26 holders.
- The largest Clovis Oncology, Inc. buyer in Q1 2014 was OppenheimerFunds, an estimated $62.5M added.
- The largest Clovis Oncology, Inc. seller in Q1 2014 was PFM Health Sciences, an estimated $111M sold.
Based on aggregated 13F filings for Q1 2014.